Full-Time

Clinical Research Coordinator

Travel

Posted on 9/4/2026

Care Access

Care Access

501-1,000 employees

Global health education, access, and research

Compensation Overview

$70k - $100k/yr

+ 401(k) company match + Bi-weekly HSA employer contribution

No H1B Sponsorship

Philadelphia, PA, USA

In Person

Nationwide travel is required 75% of the time; assignments may involve two weeks away followed by one week at home.

Bachelor's

Category
Biology & Biotech (1)
Required Skills
Phlebotomy
FDA Regulations
Word/Pages/Docs
Vital Signs
Oracle
Excel/Numbers/Sheets

Get referred to Care Access

See people who can refer or advise you

Requirements
  • Fluent written and verbal communication in both English and Spanish is required.
  • Working knowledge of clinical trials, medicine, and research terminology is required.
  • Working knowledge of federal regulations, Good Clinical Practices, Good Documentation Practices, and ALCOA-C+ is required.
  • Strong computer skills with clinical trial databases, IVR systems, electronic data capture, Microsoft Word, and Microsoft Excel are required.
  • Proficiency with clinical trial technology, including CRIO, Clinical Conductor, Clinical Ink, MediData, Oracle, Inform, ePRO, eConsent, and IWRS/IXRS, is required.
  • A minimum of 3 to 4 years of clinical research experience is required.
  • A minimum of 2 years of prior Clinical Research Coordinator experience is required.
  • Candidates must possess a valid driver's license and be able to operate rental vehicles for work-related travel.
  • Candidates must be willing to travel 75% of the time nationwide.
Responsibilities
  • Apply Good Clinical Practices while screening, enrolling, and monitoring clinical research study subjects and ensuring protocol and regulatory compliance.
  • Review protocols, study manuals, investigator drug brochures, amendments, and study requirements for clarity, feasibility, safety, and inconsistencies.
  • Assist principal investigators, regulatory staff, start-up staff, and clinical trial managers with training and study readiness.
  • Discuss study medication, procedures, eligibility criteria, and clinic-flow impacts with managers, investigators, and site staff.
  • Create recruitment and marketing materials and assist with recruitment planning.
  • Recruit study subjects by telephone and coordinate with recruitment teams and other study sites.
  • Attend investigator meetings and coordinate or attend pre-study site visits, site initiation visits, and monitoring visits.
  • Create or review protocol-specific source documents and determine facility, equipment, and outsourced-vendor requirements.
  • Ensure supplies, laboratory kits, study medication, specialized equipment, and IVRS/EDC access are available for study initiation and maintenance.
  • Educate assistant coordinators, research assistants, site staff, and sub-investigators on required tasks.
  • Manage complex trial workloads, delegate tasks, and prioritize activities according to protocol timelines and participant safety.
  • Maintain organized source documents, patient charts, case report forms, regulatory files, and study supplies.
  • Receive, inventory, dispense, monitor compliance with, and reorder investigational products; maintain accountability logs and patient records.
  • Collect and evaluate concomitant medications and biological specimens, and process and ship specimens according to protocol or laboratory manuals.
  • Prepare for monitoring visits and study teleconferences and coordinate trial activities with covering personnel.
  • Maintain adherence to Food and Drug Administration regulations and International Council for Harmonisation guidelines.
  • Communicate sponsor updates, patient concerns and progress, unforeseen issues, and trial-management information to the appropriate Care Access team members.
  • Prescreen candidates, review exclusionary conditions and medications, and schedule screening appointments.
  • Obtain informed consent and document revised informed-consent-form discussions.
  • Administer delegated study questionnaires and collect and evaluate medical records with medically qualified team members.
  • Complete visit procedures and clinical procedures such as blood draws, vital signs, and electrocardiograms; ensure proper specimen collection and shipment.
  • Review laboratory results, electrocardiograms, magnetic resonance imaging results, and other test results for completeness and alert values, and ensure timely investigator review.
  • Recognize adverse events and serious adverse events and initiate safety monitoring or symptomatic treatment as prescribed or specified in the protocol.
  • Schedule patients within visit windows and coordinate procedures to maximize workflow and patient turnaround.
  • Dispense study medication according to protocol or IVRS systems, educate patients on administration and compliance, and monitor patient progress.
  • Record source data in real time, correct errors according to standard operating procedures, and document adverse-event causality, protocol deviations, and patient progress.
  • Maintain study-medication inventory, dispensing logs, patient-compliance records, and IVRS confirmations.
  • Maintain prescriptions and patient-specific correspondence in patient charts and source records.
  • Transcribe data to case report forms or electronic data capture systems and resolve data-management queries.
  • Record protocol exemptions and deviations and complete notes-to-file when necessary.
  • Assist regulatory personnel with continuing and final review reports.
  • Perform other assigned duties.
Desired Qualifications
  • A BS in nursing, pharmacy, or another related science, or equivalent education in the arts or sciences.
  • Registered Nurse or Licensed Practical Nurse qualification.
  • Research Professional Certification from CRCC or eligibility to take the examination.
  • Clinical Research Coordinator experience at the management level.

Care Access coordinates global efforts to improve health by educating people about health, helping them access needed resources, and enabling participation in medical research to develop new medicines and cures. Its approach involves a global network and services that educate individuals, connect them with health resources, and recruit participants for clinical studies, thereby supporting the development of new treatments. Unlike companies that focus on a single market or product, Care Access operates worldwide and focuses on easing access to information, services, and research opportunities for diverse populations. The goal is to make health information and access more available and participation in health studies easier, with the aim of making the future of health better for everyone.

Company Size

501-1,000

Company Stage

N/A

Total Funding

N/A

Headquarters

Boston, Massachusetts

Founded

2016

Get referred to Care Access

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Walmart opened first Care Access sites in Texas and Georgia on 2026-04-29.
  • Care Access reported 852 employees and 163 active 2026 job postings.
  • The company added Warsaw in 2024 and CEMEC in Brazil in 2025.

What critics are saying

  • Walmart locations in Houston, Tyler, and Dalton hinge on flawless spring 2026 execution.
  • Pfizer and Valneva blamed Care Access in 2023; sponsor trust remains fragile.
  • If a major sponsor exits after a compliance failure, the decentralized model collapses.

What makes Care Access unique

  • Care Access pairs community screenings with Phase 2-4 trials inside Walmart stores, 2026.
  • Its decentralized model uses mobile clinics, Sites On Demand, and local partnerships globally.
  • Brazil, Poland, and U.S. sites create a geographically distributed recruitment engine.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Disability Insurance

Health Savings Account/Flexible Spending Account

Unlimited Paid Time Off

Paid Vacation

Paid Holidays

401(k) Retirement Plan

401(k) Company Match

Growth & Insights and Company News

Headcount

6 month growth

-4%

1 year growth

-4%

2 year growth

-4%
8th & Walton
Apr 29th, 2026
Walmart brings clinical trials into the community - walmart.com.

Walmart brings clinical trials into the community - walmart.com. Walmart is bringing clinical research into everyday community spaces through the Walmart Healthcare Research Institute and a new Clinical Trial Center collaboration with Care Access. Key takeaways. * Research closer to home: The Clinical Trial Center by Walmart and Care Access is opening initial sites in Houston and Tyler, Texas, and Dalton, Georgia, placing trial locations inside familiar store environments. * Focus on underserved communities: Walmart Healthcare Research Institute was created to expand access to clinical trials and improve care for communities historically underrepresented in research. * New model for medical innovation: Care Access will run screenings and trials, while Walmart supports outreach, with leaders describing the effort as a new way to deliver clinical research.

SmartBrief
Jan 22nd, 2026
Walmart, Care Access to partner on clinical research

Walmart, Care Access to partner on clinical research. Walmart will partner with Care Access to launch a clinical research initiative this spring that will bring clinical trial opportunities to markets, including rural areas that often lack access to cutting-edge medical research. The retailer will open research sites at select stores and former Walmart Health clinic locations. By using familiar community spaces, Walmart hopes to make participation in clinical research more accessible and convenient for local residents. Designed specifically for retail professionals, NRF SmartBrief is a free, daily email newsletter. It provides the latest need-to-know news and industry information that maximizes your time, giving you an edge over your competition.

First Free Church Chicago
Dec 1st, 2024
Care Access Senior Fair | December 6 + 7

On December 6th and 7th Firstfree is partnering with Care Access, an organization with a mission to connect the community with equitable health research.

Business Wire
Mar 18th, 2024
Care Access Opens New Clinical Research Site In Warsaw, Poland

BOSTON--(BUSINESS WIRE)--Care Access, a global clinical research site company helping to accelerate the future of medicine, has opened its newest research site in Warsaw, Poland. The company’s expansion in Poland reinforces its commitment to improving access to clinical research globally through its innovative model of bringing clinical trials wherever they are needed. In recent years, Care Access has been active in clinical research across Europe, and now, by establishing a new facility in Warsaw, Care Access is further expanding its European services aimed to implement its industry-leading research capabilities, such as its Community Screening Program, Sites On Demand, and Mobile Research Site Infrastructure. These capabilities have shown to accelerate research study enrollment by adapting to the unique makeup of each community and providing more convenient ways to participate in clinical trials. “Poland plays an important role in bringing the future of medicine to reality,” said Rupi Bancil, Senior Vice President of Global Study Operations Expansion for Care Access. “The Warsaw site will improve access to advanced health screenings and research opportunities to communities throughout Poland.”

Business Wire
Mar 4th, 2024
New Study Addressing Global Concern For Breast Cancer Treatment Now Available In Clifton, N.J.

BOSTON--(BUSINESS WIRE)--A cancer research study focusing on hormone receptor-positive HER2-negative (HR+/HER2-) metastatic breast cancer (MBC) is now available to patients in the Clifton, N.J., area. The SERENA-6 trial, sponsored by AstraZeneca, is a global study that aims to address a critical issue faced by many patients: their treatments become less effective over time. In advanced breast cancer, patients receive a treatment that combines an estrogen-reducing drug with a drug that slows cancer cell growth. While this combination works well, over time, it may stop working because of mutations in the ESR1 gene. This study will evaluate if an experimental trial drug, combined with a cancer-slowing drug, might work better than conventional estrogen-reducing drugs for patients with ESR1 mutations